SEB Bioteknikfond D vs Allianz US High Yield AM

SEB Bioteknikfond D vs Allianz US High Yield AM

1. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

2. Allianz US High Yield AM

  • Security

    Allianz US High Yield AM USD

  • Fee

    1.24%

  • ISIN

    LU0516397667

  • Holdings

    3

Fund Holdings

We have information about 24 holdings in SEB Bioteknikfond D, where the largest holding is Gilead Sciences (10.04), followed by Vertex (8.8) and Amgen (8.54). In comparison with Allianz US High Yield AM, we have 3 holdings where CCF Holdings is the largest holding (2.69), followed by Iron Mountain (2.22) and CCO Holdings LLC (2.2).

All Holdings

Here we compare the holdings in SEB Bioteknikfond D and Allianz US High Yield AM.

SEB Bioteknikfond D Allianz US High Yield AM
1. Gilead Sciences Inc
USA
10.04 %
1. CCF Holdings LLC
USA
2.69 %
2. Vertex Pharmaceuticals Inc
8.8 %
2. Iron Mountain Inc
USA
2.22 %
3. Amgen Inc
8.54 %
3. CCO Holdings LLC
USA
2.2 %
4. Regeneron Pharmaceuticals Inc
5.09 %
-
5. Alnylam Pharmaceuticals Inc
5.07 %
-
6. AstraZeneca ADR
Sweden UK
4.49 %
-
7. Verona Pharma ADR
3.46 %
-
8. Argenx ADR
2.72 %
-
9. Illumina Inc
2.72 %
-
10. BioNTech SE
2.41 %
-
11. Madrigal Pharmaceuticals Inc
1.88 %
-
12. BoneSupport AB
Sweden
1.82 %
-
13. BioMarin Pharmaceutical Inc
1.7 %
-
14. Krystal Biotech Inc
1.48 %
-
15. NewAmsterdam Pharma NV
1.46 %
-
16. BridgeBio Pharma Inc
1.45 %
-
17. Cytokinetics Inc
1.4 %
-
18. Ionis Pharmaceuticals Inc
1.37 %
-
19. Xenon Pharmaceuticals
1.37 %
-
20. Insmed Inc
1.32 %
-
21. Onward Medical NV
1.31 %
-
22. Janux Therapeutics Inc
1.3 %
-
23. Structure Therapeutics ADR
1.24 %
-
24. Kymera Therapeutics Inc
1.09 %
-

The list of fund holdings was last updated on April 17, 2025.